Dana Marshall is a Dermatology physician affiliated with Meharry Medical College. OpenAlex indexes 79 publications with 2,159 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2600 Belle Chasse Hwy Ste 202
Terrytown, LA 700567156
Telephone
504-393-7393Provider last certified this registry record 18 Jul 2024.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year202515 payments
- ABBVIE INC.Program year202553 payments
- UCB, Inc.Program year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
34%Azole Antifungal17.7%Ketoconazole88%Fluconazole12%Part D≥69 patientsTetracycline-class Drug9.2%Doxycycline Hyclate100%Part D≥41 patients+ 3 more classes in this area
Cardiovascular
19.3%Arteriolar Vasodilator13.7%Minoxidil100%Part D≥41 patientsCorticosteroid5.5%Fluocinonide100%Part D≥30 patientsSensory organs
13.2%Corticosteroid13.2%Clobetasol Propionate54%Hydrocortisone46%Part D≥42 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Role of Fetuin-A in Tumor Cell Growth, Prognosis, and Dissemination
International Journal of Molecular Sciences
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Benedict Maliakkal, MD
Meharry Medical College
Alfred Callahan, MD
Meharry Medical College
Ravi Gandhi, MD
Meharry Medical College
Thelma Hurd, MD
Meharry Medical College
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”